Search Within

Martin Henner Voss

Formats
  1. Meeting Abstract (150)
  2. Journal Article (122)
  3. Review (6)
  4. Editorial (5)
  5. Guidelines (2)
  6. Research Letter (2)
  7. Correspondence (1)
Groups
  1. Department of Medicine (288)
  2. Genitourinary Oncology Service (288)
  3. Solid Tumor Oncology Division (288)
  4. Human Oncology and Pathogenesis Program (104)
  5. Weinberg Fellows (104)
  6. Surgery (103)

More Groups

People
  1. Robert Motzer (176)
  2. Abraham Hakimi (95)
  3. Darren Feldman (80)
  4. Chung-Han Lee (75)
  5. Maria Carlo (65)
  6. Ritesh Kotecha (63)

More People

Years
  1. 2025 (6)
  2. 2024 (15)
  3. 2023 (21)
  4. 2022 (24)
  5. 2021 (30)
  6. 2020 (23)

More Years

Publications
  1. Journal of Clinical Oncology (116)
  2. Clinical Cancer Research (18)
  3. BJU International (15)
  4. Annals of Oncology (13)
  5. Journal for ImmunoTherapy of Cancer (12)
  6. Clinical Genitourinary Cancer (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (120)
  2. American Association for Cancer Research (26)
  3. Wiley Blackwell (22)
  4. Elsevier Inc. (21)
  5. Oxford University Press (18)
  6. Biomed Central Ltd (15)

More Publishers

Results (288)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment-free survival after immune checkpoint inhibitor therapy versus targeted therapy for advanced renal cell carcinoma: 42-month results of the CheckMate 214 trial
    Journal Article

    Regan, M. M.; Jegede, O. A.; Mantia, C. M.; Powles, T.; Werner, L.; Motzer, R. J.; Tannir, N. M.; Lee, C. H.; Tomita, Y.; Voss, M. H.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Novel emerging biomarkers to immunotherapy in kidney cancer
    Review

    Ged, Y.; Voss, M. H.
    Therapeutic Advances in Medical Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes of patients who progressed while receiving avelumab + axitinib (A + Ax) and received subsequent treatment (Tx) in JAVELIN Renal 101
    Meeting Abstract

    Albiges, L.; Voss, M. H.; Rini, B. I.; Gravis, G.; Grimm, M. O.; Nathan, P. D.; Bjarnason, G. A.; Tomita, Y.; Penkov, K.; McGregor, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Reznik, E.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Tassone, D.; Dadoun, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Provision of subspecialized expert oncology (SEO) opinions using Navya Cancer Data Model (NCDM), a technology-based platform: Prospective study to facilitate access to care
    Meeting Abstract

    Traina, T. A.; Kantoff, P. W.; Matasar, M. J.; Dunn, L.; Friedman, C. F.; Voss, M. H.; Seidman, A. D.; Cahlon, O.; Zauderer, M. G.; Manship, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of fibroblast growth factor receptor inhibitor-associated retinopathy
    Journal Article

    Francis, J. H.; Harding, J. J.; Schram, A. M.; Canestraro, J.; Haggag-Lindgren, D.; Heinemann, M.; Kriplani, A.; Jhaveri, K.; Voss, M. H.; Bajorin, D.; more...
    JAMA Ophthalmology (2021)

    Fulltext@MSK | Save
  • Randomized, open-label, 3-arm phase III study comparing MK-1308A + lenvatinib and pembrolizumab (pembro) + belzutifan + lenvatinib versus pembro + lenvatinib as first-line (1L) treatment for advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Rini, B. I.; Plimack, E. R.; Powles, T. B.; Voss, M. H.; Gurney, H. P.; Silverman, R.; Perini, R.; Rodriguez-Lopez, K.; Choueiri, T. K.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • A qualitative framework of non-selection factors for cytoreductive nephrectomy
    Journal Article

    Silagy, A. W.; Attalla, K.; Dinatale, R. G.; Weiss, K. L.; Weng, S.; Mano, R.; Iosepovici, S.; Marcon, J.; Reznik, E.; Kotecha, R. R.; more...
    World Journal of Urology (2021)

    Fulltext@MSK | Save
  • A phase I/II study to assess the safety and efficacy of pazopanib and pembrolizumab combination therapy in patients with advanced renal cell carcinoma
    Journal Article

    Chowdhury, S.; Infante, J. R.; Hawkins, R.; Voss, M. H.; Perini, R.; Arkenau, T.; Voskoboynik, M.; Aimone, P.; Naeije, I.; Reising, A.; more...
    Clinical Genitourinary Cancer (2021)

    Fulltext@MSK | Save
  • Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma
    Journal Article

    Silagy, A. W.; Kotecha, R. R.; Weng, S.; Holmes, A.; Singla, N.; Mano, R.; Attalla, K.; Weiss, K. L.; DiNatale, R. G.; Patil, S.; more...
    Cancer (2021)

    Fulltext@MSK | Save